Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma: Myeloma

CD307 is a differentiation antigen expressed in B-lineage cells. One soluble and two membrane-bound forms have been predicted and an enzyme-linked immunosorbent assay (ELISA) for soluble CD307 established. Our goal was to determine if CD307 is expressed on the surface of cells from patients with mul...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Leukemia 2007-01, Vol.21 (1), p.169-174
Hauptverfasser:	Ise, T, Nagata, S, Kreitman, R J, Wilson, W H, Wayne, A S, Stetler-Stevenson, M, Bishop, M R, Scheinberg, D A, Rassenti, L, Kipps, T J, Kyle, R A, Jelinek, D F, Pastan, I
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Research Critical Care Medicine Hematology Intensive Internal Medicine Medicine Medicine & Public Health Oncology original-article
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!